» Articles » PMID: 27824100

Identification of a New Broadly Cross-reactive Epitope Within Domain III of the Duck Tembusu Virus E Protein

Overview
Journal Sci Rep
Specialty Science
Date 2016 Nov 9
PMID 27824100
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In 2010, a pathogenic flavivirus termed duck Tembusu virus (DTMUV) caused widespread outbreak of egg-drop syndrome in domesticated ducks in China. Although the glycoprotein E of DTMUV is an important structural component of the virus, the B-cell epitopes of this protein remains uncharacterized. Using phage display and mutagenesis, we identified a minimal B-cell epitope, EXE/DPPFG, that mediates binding to a nonneutralizing monoclonal antibody. DTMUV-positive duck serum reacted with the epitope, and amino acid substitutions revealed the specific amino acids that are essential for antibody binding. Dot-blot assays of various flavivirus-positive sera indicated that EXE/DPPFG is a cross-reactive epitope in most flaviviruses, including Zika, West Nile, Yellow fever, dengue, and Japanese encephalitis viruses. These findings indicate that the epitope sequence is conserved among many strains of mosquito-borne flavivirus. Protein structure modeling revealed that the epitope is located in domain III of the DTMUV E protein. Together, these results provide new insights on the broad cross-reactivity of a B-cell binding site of the E protein of flaviviruses, which can be exploited as a diagnostic or therapeutic target for identifying, studying, or treating DTMUV and other flavivirus infections.

Citing Articles

Fitness adaptations of Japanese encephalitis virus in pigs following vector-free serial passaging.

Marti A, Nater A, Pego Magalhaes J, Almeida L, Lewandowska M, Liniger M PLoS Pathog. 2024; 20(8):e1012059.

PMID: 39186783 PMC: 11379391. DOI: 10.1371/journal.ppat.1012059.


Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.

Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L Nat Commun. 2024; 15(1):1696.

PMID: 38402207 PMC: 10894228. DOI: 10.1038/s41467-024-45806-x.


Study on the Protective Immunity Induced by Pseudotyped Baculovirus Expressing the E Protein of Tembusu Virus in Ducklings.

Ni Z, Yun T, Chen L, Ye W, Hua J, Zhu Y Genes (Basel). 2023; 14(7).

PMID: 37510221 PMC: 10378915. DOI: 10.3390/genes14071316.


Serological cross-reactivity among common flaviviruses.

Chan K, Ismail A, Thergarajan G, Raju C, Yam H, Rishya M Front Cell Infect Microbiol. 2022; 12:975398.

PMID: 36189346 PMC: 9519894. DOI: 10.3389/fcimb.2022.975398.


Substitutions at Loop Regions of TMUV E Protein Domain III Differentially Impair Viral Entry and Assembly.

Hu T, Wu Z, Wu S, Wang M, Jia R, Zhu D Front Microbiol. 2021; 12:688172.

PMID: 34262547 PMC: 8273266. DOI: 10.3389/fmicb.2021.688172.


References
1.
Burland T . DNASTAR's Lasergene sequence analysis software. Methods Mol Biol. 1999; 132:71-91. DOI: 10.1385/1-59259-192-2:71. View

2.
Goncalvez A, Purcell R, Lai C . Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol. 2004; 78(23):12919-28. PMC: 525008. DOI: 10.1128/JVI.78.23.12919-12928.2004. View

3.
Crill W, Chang G . Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol. 2004; 78(24):13975-86. PMC: 533943. DOI: 10.1128/JVI.78.24.13975-13986.2004. View

4.
Oliphant T, Engle M, Nybakken G, Doane C, Johnson S, Huang L . Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med. 2005; 11(5):522-30. PMC: 1458527. DOI: 10.1038/nm1240. View

5.
Stiasny K, Kiermayr S, Holzmann H, Heinz F . Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol. 2006; 80(19):9557-68. PMC: 1617264. DOI: 10.1128/JVI.00080-06. View